Decitabine Induces Change of Biological Traits in Myelodysplastic Syndromes via FOXO1 Activation
Decitabine (DAC) is considered to be a profound global DNA demethylation, which can induce the re-expression of silenced tumor suppressor genes. Little is known about the function of tumor suppressor gene FOXO1 in myelodysplastic syndromes (MDS). To address this issue, the study firstly investigated...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Frontiers Media S.A.
2021-01-01
|
| Ráidu: | Frontiers in Genetics |
| Fáttát: | |
| Liŋkkat: | https://www.frontiersin.org/articles/10.3389/fgene.2020.603956/full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|